These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29063386)

  • 1. Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers.
    Pfortmueller CA; Meisel C; Fux M; Schefold JC
    Intensive Care Med Exp; 2017 Oct; 5(1):49. PubMed ID: 29063386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.
    Spinetti T; Hirzel C; Fux M; Walti LN; Schober P; Stueber F; Luedi MM; Schefold JC
    Anesth Analg; 2020 Oct; 131(4):993-999. PubMed ID: 32925314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis.
    Joshi I; Carney WP; Rock EP
    Front Immunol; 2023; 14():1130214. PubMed ID: 36825018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients.
    Tschaikowsky K; Hedwig-Geissing M; Schiele A; Bremer F; Schywalsky M; Schüttler J
    Crit Care Med; 2002 May; 30(5):1015-23. PubMed ID: 12006796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of monocyte HLA-DR expression over time with secondary infection in critically ill children: a prospective observational study.
    Hagedoorn NN; Kolukirik P; Nagtzaam NMA; Nieboer D; Verbruggen S; Joosten KF; Moll H; Driessen G; Dik WA; Vermont C
    Eur J Pediatr; 2022 Mar; 181(3):1133-1142. PubMed ID: 34755207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries-Insights from the REALISM Study.
    Bidar F; Bodinier M; Venet F; Lukaszewicz AC; Brengel-Pesce K; Conti F; Quemeneur L; Leissner P; Tan LK; Textoris J; Rimmelé T; Monneret G; On Behalf Of The Realism Study Group
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spinal cord injury-induced immune deficiency syndrome: results of the SCIentinel study.
    Kopp MA; Meisel C; Liebscher T; Watzlawick R; Cinelli P; Schweizerhof O; Blex C; Lübstorf T; Prilipp E; Niedeggen A; Druschel C; Schaser KD; Wanner GA; Curt A; Lindemann G; Nugeva N; Fehlings MG; Vajkoczy P; Cabraja M; Dengler J; Ertel W; Ekkernkamp A; Rehahn K; Martus P; Volk HD; Unterwalder N; Kölsch U; Brommer B; Hellmann RC; Baumgartner E; Hirt J; Geurtz LC; Saidy RRO; Prüss H; Laginha I; Failli V; Grittner U; Dirnagl U; Schwab JM
    Brain; 2023 Aug; 146(8):3500-3512. PubMed ID: 37370200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Interferon- γ Rescues Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) Function in a COVID-19 Patient With ARDS and Superinfection With Multiple MDR 4MRGN Bacterial Strains.
    Grimm C; Dickel S; Grundmann J; Payen D; Schanz J; Zautner AE; Tampe B; Moerer O; Winkler MS
    Front Immunol; 2021; 12():753849. PubMed ID: 34790197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity recovers earlier than acquired immunity during severe postoperative immunosuppression.
    Lachmann G; von Haefen C; Kurth J; Yuerek F; Spies C
    Int J Med Sci; 2018; 15(1):1-9. PubMed ID: 29333081
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) Study.
    Peronnet E; Blein S; Venet F; Cerrato E; Fleurie A; Llitjos JF; Kreitmann L; Terraz G; Conti F; Gossez M; Rimmelé T; Textoris J; Lukaszewicz AC; Brengel-Pesce K; Monneret G;
    Crit Care Med; 2023 Jun; 51(6):808-816. PubMed ID: 36917594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Leukocyte Antigen-DR Isotype Expression in Monocytes and T Cells Interferon-Gamma Release Assay in Septic Patients and Correlation With Clinical Outcome.
    Greco M; Mazzei A; Suppressa S; Palumbo C; Verri T; Lobreglio G
    J Clin Med Res; 2021 May; 13(5):293-303. PubMed ID: 34104281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses-A
    Tamulyte S; Kopplin J; Brenner T; Weigand MA; Uhle F
    Front Immunol; 2019; 10():432. PubMed ID: 30915080
    [No Abstract]   [Full Text] [Related]  

  • 13. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction.
    Lukaszewicz AC; Grienay M; Resche-Rigon M; Pirracchio R; Faivre V; Boval B; Payen D
    Crit Care Med; 2009 Oct; 37(10):2746-52. PubMed ID: 19707128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Profiling Panel: A Proof-of-Concept Study of a New Multiplex Molecular Tool to Assess the Immune Status of Critically Ill Patients.
    Tawfik DM; Vachot L; Bocquet A; Venet F; Rimmelé T; Monneret G; Blein S; Montgomery JL; Hemmert AC; Pachot A; Moucadel V; Yugueros-Marcos J; Brengel-Pesce K; Mallet F; Textoris J
    J Infect Dis; 2020 Jul; 222(Suppl 2):S84-S95. PubMed ID: 32691839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?
    Winkler MS; Rissiek A; Priefler M; Schwedhelm E; Robbe L; Bauer A; Zahrte C; Zoellner C; Kluge S; Nierhaus A
    PLoS One; 2017; 12(8):e0182427. PubMed ID: 28771573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients.
    Rol ML; Venet F; Rimmele T; Moucadel V; Cortez P; Quemeneur L; Gardiner D; Griffiths A; Pachot A; Textoris J; Monneret G;
    BMJ Open; 2017 Jun; 7(6):e015734. PubMed ID: 28637738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock.
    Venet F; Tissot S; Debard AL; Faudot C; Crampé C; Pachot A; Ayala A; Monneret G
    Crit Care Med; 2007 Aug; 35(8):1910-7. PubMed ID: 17568330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low monocytic HLA-DR expression and risk of secondary infection].
    Chéron A; Monneret G; Landelle C; Floccard B; Allaouchiche B
    Ann Fr Anesth Reanim; 2010 May; 29(5):368-76. PubMed ID: 20356708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine Removal in Critically Ill Patients Requiring Surgical Therapy for Infective Endocarditis (RECReATE): An Investigator-initiated Prospective Randomized Controlled Clinical Trial Comparing Two Established Clinical Protocols.
    Gisler F; Spinetti T; Erdoes G; Luedi MM; Pfortmueller CA; Messmer AS; Jenni H; Englberger L; Schefold JC
    Medicine (Baltimore); 2020 Apr; 99(15):e19580. PubMed ID: 32282706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis.
    Berres ML; Schnyder B; Yagmur E; Inglis B; Stanzel S; Tischendorf JJ; Koch A; Winograd R; Trautwein C; Wasmuth HE
    Liver Int; 2009 Apr; 29(4):536-43. PubMed ID: 18795898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.